Core Laboratories (NYSE:CLB) Issues Q3 2025 Earnings Guidance

Core Laboratories (NYSE:CLB - Get Free Report) issued an update on its third quarter 2025 earnings guidance on Wednesday morning. The company provided earnings per share guidance of 0.180-0.220 for the period, compared to the consensus earnings per share estimate of 0.220. The company issued revenue guidance of $127.5 million-$134.5 million, compared to the consensus revenue estimate of $129.6 million.

Core Laboratories Trading Down 12.2%

Shares of CLB traded down $1.63 during mid-day trading on Friday, reaching $11.73. The stock had a trading volume of 815,069 shares, compared to its average volume of 522,286. The company has a debt-to-equity ratio of 0.47, a current ratio of 2.27 and a quick ratio of 1.64. Core Laboratories has a 52-week low of $10.14 and a 52-week high of $25.13. The business's fifty day moving average is $11.83 and its 200 day moving average is $13.87. The firm has a market cap of $549.75 million, a price-to-earnings ratio of 18.91, a P/E/G ratio of 3.61 and a beta of 1.41.

Core Laboratories (NYSE:CLB - Get Free Report) last announced its quarterly earnings data on Wednesday, July 23rd. The oil and gas company reported $0.19 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $0.18 by $0.01. Core Laboratories had a net margin of 5.73% and a return on equity of 14.15%. The firm had revenue of $130.16 million during the quarter, compared to analyst estimates of $129.19 million. During the same quarter in the prior year, the firm posted $0.22 earnings per share. Core Laboratories's quarterly revenue was down .3% on a year-over-year basis. On average, sell-side analysts predict that Core Laboratories will post 0.96 EPS for the current fiscal year.

Core Laboratories Dividend Announcement

The business also recently announced a quarterly dividend, which will be paid on Monday, August 25th. Shareholders of record on Monday, August 4th will be paid a dividend of $0.01 per share. This represents a $0.04 annualized dividend and a yield of 0.34%. The ex-dividend date is Monday, August 4th. Core Laboratories's dividend payout ratio (DPR) is presently 6.45%.

Analysts Set New Price Targets

CLB has been the subject of several research analyst reports. Citigroup lowered their target price on shares of Core Laboratories from $16.00 to $13.00 and set a "neutral" rating for the company in a research note on Tuesday, May 13th. Wall Street Zen raised shares of Core Laboratories from a "sell" rating to a "hold" rating in a research note on Saturday. Finally, Stifel Nicolaus lowered their target price on shares of Core Laboratories from $13.00 to $12.00 and set a "hold" rating for the company in a research note on Wednesday, July 16th.

Institutional Inflows and Outflows

An institutional investor recently raised its position in Core Laboratories stock. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. grew its holdings in Core Laboratories Inc. (NYSE:CLB - Free Report) by 4.4% in the 1st quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 27,893 shares of the oil and gas company's stock after purchasing an additional 1,170 shares during the quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. owned 0.06% of Core Laboratories worth $418,000 at the end of the most recent reporting period. Institutional investors own 97.81% of the company's stock.

Core Laboratories Company Profile

Core Laboratories Inc provides reservoir description and production enhancement services and products to the oil and gas industry in the United States, and internationally. It operates through Reservoir Description and Production Enhancement segments. The Reservoir Description segment includes the characterization of petroleum reservoir rock and reservoir fluid samples to enhance production and improve recovery of crude oil and gas from its clients' reservoirs.